Patents by Inventor Elizabeth J. Shpall

Elizabeth J. Shpall has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220265718
    Abstract: Provided herein are immune cells expressing antigenic receptors, such as a chimeric antigen receptor and a T cell receptor. Further provided herein are methods of treating immune-related disorder by administering the antigen-specific immune cells.
    Type: Application
    Filed: April 28, 2022
    Publication date: August 25, 2022
    Inventors: Katy REZVANI, Elizabeth J. SHPALL
  • Patent number: 11344578
    Abstract: Provided herein are immune cells expressing antigenic receptors, such as a chimeric antigen receptor and a T cell receptor. Further provided herein are methods of treating immune-related disorder by administering the antigen-specific immune cells.
    Type: Grant
    Filed: April 19, 2018
    Date of Patent: May 31, 2022
    Assignee: BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Katy Rezvani, Elizabeth J. Shpall
  • Publication number: 20200085872
    Abstract: Provided herein are immune cells expressing antigenic receptors, such as a chimeric antigen receptor and a T cell receptor. Further provided herein are methods of treating immune-related disorder by administering the antigen-specific immune cells.
    Type: Application
    Filed: April 19, 2018
    Publication date: March 19, 2020
    Inventors: Katy REZVANI, Elizabeth J. SHPALL
  • Publication number: 20190262442
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Application
    Filed: January 7, 2019
    Publication date: August 29, 2019
    Applicant: Board of Regents, The University of Texas System
    Inventors: William K. DECKER, Elizabeth J. SHPALL, Krishna V. KOMANDURI, Dongxia XING
  • Patent number: 9993537
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Grant
    Filed: April 19, 2016
    Date of Patent: June 12, 2018
    Assignee: Board of Regents, The University of Texas System
    Inventors: William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing
  • Publication number: 20160263206
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Application
    Filed: April 19, 2016
    Publication date: September 15, 2016
    Applicant: Board of Regents, The University of Texas System
    Inventors: William K. DECKER, Elizabeth J. SHPALL, Krishna V. KOMANDURI, Dongxia XING
  • Patent number: 9333248
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Grant
    Filed: April 9, 2014
    Date of Patent: May 10, 2016
    Assignee: Board of Regents, The University of Texas System
    Inventors: William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing
  • Publication number: 20140286975
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Application
    Filed: April 9, 2014
    Publication date: September 25, 2014
    Applicant: THE BOARD OF REGENTS, THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: William K. DECKER, Elizabeth J. SHPALL, Krishna V. KOMANDURI, Dongxia XING
  • Patent number: 8728806
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Grant
    Filed: December 4, 2009
    Date of Patent: May 20, 2014
    Assignee: The Board of Regents, The University of Texas System
    Inventors: William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing
  • Publication number: 20110306948
    Abstract: Certain embodiments of the invention are directed to methods for inducing an immunologic response to a tumor in a patient using mature dendritic cells transfected with a nucleic acid composition encoding one or more tumor antigens and loaded with a corresponding tumor antigen composition.
    Type: Application
    Filed: December 4, 2009
    Publication date: December 15, 2011
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: William K. Decker, Elizabeth J. Shpall, Krishna V. Komanduri, Dongxia Xing